Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 1998, p. 219-222, Vol. 36, No. 1
Division of Infectious Diseases,
Received 27 June 1997/Accepted 8 October 1997
Staphylococcus aureus isolates which produce type A
staphylococcal
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Association of Borderline Oxacillin-Susceptible
Strains of Staphylococcus aureus with Surgical Wound
Infections
-lactamase have been associated with wound infections complicating the use of cefazolin prophylaxis in surgery. To further evaluate this finding, 215 wound isolates from 14 cities in the United
States were characterized by antimicrobial susceptibility and
-lactamase type and correlated with the preoperative prophylactic regimen. Borderline-susceptible S. aureus isolates of phage
group 5 (BSSA-5), which produce large amounts of type A
-lactamase and exhibit borderline susceptibility to oxacillin, comprised a greater
percentage of the 120 wound isolates associated with cefazolin
prophylaxis than they did of the 95 isolates associated with other
prophylactic regimens (25% versus 12.6%, respectively; P < 0.05). In contrast, methicillin-resistant
S. aureus isolates were distributed evenly between the two
groups (8.3% versus 11.6%, respectively). In vitro assays
demonstrated that cefazolin was hydrolyzed faster by BSSA-5 strains
than by other
-lactamase-producing, methicillin-susceptible strains
(1.54 versus 0.50 µg/min/108 CFU, respectively;
P < 0.0001). These data demonstrate that BSSA-5 strains are a distinct subpopulation of methicillin-susceptible S. aureus which frequently cause deep surgical wound
infections. Cefazolin use in prophylaxis is a risk factor for BSSA-5
infection.
*
Corresponding author. Mailing address: Division of
Infectious Diseases, A-3310 MCN, Vanderbilt University Medical Center, Garland and 21st Ave. South, Nashville, TN 37232-2605. Phone: (615)
327-4751, ext. 5512. Fax: (615) 321-6327. E-mail:
kernodds{at}ctrvax.vanderbilt.edu.
Journal of Clinical Microbiology, January 1998, p. 219-222, Vol. 36, No. 1
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»